1.45 (-%)
As of Nov 01, 2024
Source:
Alx Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 immune checkpoint and bridge the innate and adaptive immune system.
Country | United States |
Headquarters | south san francisco, california |
Phone Number | 650-466-7125 |
Industry | manufacturing |
CEO | Jason Lettmann |
Website | alxoncology.com |